Philadelphia, Pennsylvania--(Newsfile Corp. - October 19, 2025) - Grabar Law Office is investigating claims on behalf of shareholders of Baxter International Inc. (NYSE: BAX). Alternatively, if you purchased Baxter shares between February 23, 2022 and July 30, 2025, you can participate in the class action. Major national news outlets did not pick up the story, allowing Baxter to contain the fallout and continue misleading investors about the success of the Novum LVP rollout. Then, on July 14, 2025, Baxter issued a second warning letter reiterating an underinfusion risk along with an additional risk of overinfusion. Alternatively, if you purchased Baxter shares between February 23, 2022 and July 30, 2025, you can participate in the class action.